Steven K. Galson, Director: Biocryst Pharmaceuticals BCRX Buy · Filed 24/05/15

Trade details

Type: Insider buy
Amount: $120,450.6
Shares · price: 21,940 sh · $5.49 a share
Held after: 51,551 sh
Stock: Biocryst Pharmaceuticals BCRX
Person: Steven K. GalsonDirector
Trade date: 24/05/13
Filed: 24/05/15
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 8 insiders
Holding change: +74.1%

Biocryst Pharmaceuticals trades, last 26 weeks

What else happened in Biocryst Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/04/13~24/06/12

Steven K. Galson's recent trades

No other trades yet.